Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

VolitionRX Q2 EPS $(0.06) Misses $(0.05) Estimate, Sales $406.688K Beat $379.000K Estimate

Author: Benzinga Newsdesk | August 14, 2025 04:30pm
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 25 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $406.688 thousand which beat the analyst consensus estimate of $379.000 thousand by 7.31 percent. This is a 2.75 percent increase over sales of $395.797 thousand the same period last year.

Posted In: VNRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist